日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proteomic Analysis of PTEN-Deficient Cells Reveals Src-Mediated Upregulation of EphA2 and Therapeutic Potential of Dual Inhibition

PTEN缺陷细胞的蛋白质组学分析揭示了Src介导的EphA2上调以及双重抑制的治疗潜力

Wang, Qiong; Kong, Xiangyi; Song, Hongming; Wang, Li; Li, Lingrui; Hou, Xiaonan; Renuse, Santosh; Zahari, Muhammad Saddiq; Cheng, Ran; Khan, Md Kamrul Hasan; Wang, Jidong; Mangalaparthi, Kiran; Fang, Lin; Lotan, Tamara Levin; Park, Ben Ho; Weroha, S John; Zhou, Huaijun; Pandey, Akhilesh; Wu, Xinyan

Correction to: Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts

更正:定量磷酸化蛋白质组学分析揭示了癌上皮细胞和基质成纤维细胞之间受体酪氨酸激酶的相互激活

Wu, Xinyan; Zahari, Muhammad Saddiq; Renuse, Santosh; Sahasrabuddhe, Nandini A; Chaerkady, Raghothama; Kim, Mi-Sik; Fackler, Mary Jo; Stampfer, Martha; Gabrielson, Edward; Sukumar, Saraswati; Pandey, Akhilesh

Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts

定量磷酸化蛋白质组学分析揭示了癌上皮细胞和基质成纤维细胞之间受体酪氨酸激酶的相互激活

Wu, Xinyan; Zahari, Muhammad Saddiq; Renuse, Santosh; Sahasrabuddhe, Nandini A; Chaerkady, Raghothama; Kim, Min-Sik; Fackler, Mary Jo; Stampfer, Martha; Gabrielson, Edward; Sukumar, Saraswati; Pandey, Akhilesh

The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer

非受体酪氨酸激酶 TNK2/ACK1 是三阴性乳腺癌的新治疗靶点

Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, Dhanashree S Kelkar, Mustafa A Barbhuiya, Pamela L Rojas, Vered Stearns, Edward Gabrielson, Pavani Malla, Saraswati Sukumar, Nupam P Mahajan, Akhilesh Pandey

Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer

磷酸化蛋白质组学分析确定粘着斑激酶 2 (FAK2) 是乳腺癌他莫昔芬耐药的潜在治疗靶点

Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, Raja Sekhar Nirujogi, Min-Sik Kim, Srikanth S Manda, Vered Stearns, Edward Gabrielson, Saraswati Sukumar, Akhilesh Pandey

Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemia

肿瘤组织的磷酸化蛋白质组学分析表明 HSP27 Ser82 磷酸化是早期缺血的有力标志物

Muhammad Saddiq Zahari, Xinyan Wu, Sneha M Pinto, Raja Sekhar Nirujogi, Min-Sik Kim, Barry Fetics, Mathew Philip, Sheri R Barnes, Beverly Godfrey, Edward Gabrielson, Erez Nevo, Akhilesh Pandey

Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome

PIK3CA 的激活突变导致酪氨酸磷酸化蛋白质组的广泛调节

Muhammad Saddiq Zahari #, Xinyan Wu #, Brian G Blair, Sneha M Pinto, Raja S Nirujogi, Christine A Jelinek, Radhika Malhotra, Min-Sik Kim, Ben Ho Park, Akhilesh Pandey

A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations

磷酸化蛋白质组学筛选表明,不同的 PIK3CA 突变对 HER3 的 MAP 激酶通路激活具有不同的依赖性

Brian G Blair, Xinyan Wu, Muhammad Saddiq Zahari, Morassa Mohseni, Justin Cidado, Hong Yuen Wong, Julia A Beaver, Rory L Cochran, Daniel J Zabransky, Sarah Croessmann, David Chu, Patricia Valda Toro, Karen Cravero, Akhilesh Pandey, Ben Ho Park

Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways

三阴性乳腺癌中的全球磷酸酪氨酸调查揭示了多种酪氨酸激酶信号通路的激活

Xinyan Wu, Muhammad Saddiq Zahari, Binyun Ma, Ren Liu, Santosh Renuse, Nandini A Sahasrabuddhe, Lily Chen, Raghothama Chaerkady, Min-Sik Kim, Jun Zhong, Christine Jelinek, Mustafa A Barbhuiya, Pamela Leal-Rojas, Yi Yang, Manoj Kumar Kashyap, Arivusudar Marimuthu, Min Ling, Mary Jo Fackler, Vanessa M

Activation of diverse signalling pathways by oncogenic PIK3CA mutations

致癌 PIK3CA 突变激活多种信号通路

Xinyan Wu, Santosh Renuse, Nandini A Sahasrabuddhe, Muhammad Saddiq Zahari, Raghothama Chaerkady, Min-Sik Kim, Raja S Nirujogi, Morassa Mohseni, Praveen Kumar, Rajesh Raju, Jun Zhong, Jian Yang, Johnathan Neiswinger, Jun-Seop Jeong, Robert Newman, Maureen A Powers, Babu Lal Somani, Edward Gabrielson